Is AbbVie Stock Too Cheap to Ignore at Today's Price? [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
AbbVie is also an excellent dividend stock. 10 stocks we like better than AbbVie › AbbVie (NYSE: ABBV) , a pharmaceutical leader, has faced some challenges over the past three years. The company is managing some patent cliffs and clinical setbacks that worried investors and dinged its stock price. Despite all that, the stock still performed well over this period. Yet, there is an argument to be made that AbbVie remains attractively valued and will grow into its valuation over the next five years or so, delivering market-beating returns in the process. Let's consider two metrics that help make a case for AbbVie's shares being undervalued at current levels. First, the stock trades at 16.8 times forward earnings . That's slightly lower than the 18.3 average for the healthcare sector , and the 22.6 average for the S&P 500 . AbbVie's price/earnings-to-growth (PEG ratio) of 0.43 also puts the stock well within the undervalued range. Of course, numbers can't tell us everything. But th
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 [Yahoo! Finance]Yahoo! Finance
- AbbVie (NYSE:ABBV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- Hot Picks: Large-cap health care stocks to watch for dividend growth [BNN Bloomberg (Canada)]BNN Bloomberg
- AbbVie (NYSE:ABBV) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.MarketBeat
- AbbVie (NYSE:ABBV) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.MarketBeat
ABBV
Earnings
- 10/31/25 - Beat
ABBV
Sec Filings
- 11/20/25 - Form F-6
- 11/4/25 - Form 10-Q
- 10/31/25 - Form 8-K
- ABBV's page on the SEC website